Quantcast

Latest Multi-drug-resistant tuberculosis Stories

2009-08-13 07:45:00

KOLKATA, India, Aug. 13 /PRNewswire-USNewswire/ -- Lilly MDR TB Partnership and Children International launched a yearlong public awareness campaign aimed to bolster the TB eradication in India.

01584c925e8dfe01636470d240157784
2009-07-03 09:55:00

Drugs used to care for Parkinson's disease might be a new way to halt the increase of drug-resistant forms of tuberculosis.

2009-06-17 10:00:00

Price reductions for liquid culture tests will accelerate access to improved TB diagnostics SEATTLE, June 17 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company; NYSE: BDX), a leading global medical technology company, and FIND (Foundation for Innovative New Diagnostics), a Swiss foundation that develops, evaluates and accelerates the implementation of new diagnostic tools for poverty-related diseases, today announced a significant price reduction in the cost of liquid culture...

2009-06-17 08:15:00

SEATTLE, June 17 /PRNewswire/ -- When: Wednesday, June 17, 2009, 10:30am Eastern (9:30am Central; 8:30am Mountain; 7:30am Pacific) Dial-in: 1-877-879-6184 (toll-free) 1-719-325-4759 (local access) Conference Title: TB Alliance/Tibotec Briefing Participant passcode: 2895940 Where: Pacific Health Summit Bell Harbor International Conference Center Pacific Board Room Seattle,...

2009-06-17 07:00:00

Collaboration will focus on the development of TMC207 and the discovery of new drugs to treat tuberculosis SEATTLE, June 17 /PRNewswire/ -- A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec Inc., (Tibotec), a global pharmaceutical company, has been announced today at the Pacific Health Summit in response to the urgent need to accelerate the discovery and development of new drugs to...

2009-06-03 16:00:00

Clinical Activity Of TMC207 shows ATP-Synthase is a Viable Target for treatment of TB MECHELEN, Belgium, June 3 /PRNewswire/ -- Interim results from an ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207 for the treatment of multidrug-resistant tuberculosis (MDR-TB) were published in the New England Journal of Medicine today.

2009-04-27 06:00:00

Unique GeneXpert(R) System Capabilities Enable Powerful New TB Diagnostic Tool SUNNYVALE, Calif., April 27 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the release of Xpert(R) MTB/RIF as a CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices.

e171a821faa7a10015db7cd86436e2431
2009-04-16 11:22:34

Countries in the former Soviet Union and many regions of China are facing an epidemic of multi-drug resistant tuberculosis, according to a new report based on data from 90,000 patients in 83 countries.

f6152e3f54a6a323968cc17186718df7
2009-04-03 10:00:00

According to a study reported in The Lancet on Saturday, a new antibiotic has passed a key phase in a test of drugs aimed at shortening the time to cure tuberculosis, offering a potential boon in the fight against TB.

2009-03-30 11:37:12

The discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB), in the lungs of TB patients could be an important step forward in the design of new anti-TB drugs.


Word of the Day
megalophonous
  • Having a loud voice; vociferous; clamorous.
  • Of grand or imposing sound.
The word 'megalophonous' comes from Greek roots meaning 'big' and 'sound'.